EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 162 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $56,000 | -32.5% | 2,115 | +12.7% | 0.00% | 0.0% |
| Q2 2022 | $83,000 | +2.5% | 1,877 | +14.7% | 0.00% | 0.0% |
| Q1 2022 | $81,000 | +2.5% | 1,637 | +5.5% | 0.00% | 0.0% |
| Q4 2021 | $79,000 | -8.1% | 1,552 | +1.0% | 0.00% | 0.0% |
| Q3 2021 | $86,000 | +21.1% | 1,537 | -7.3% | 0.00% | 0.0% |
| Q2 2021 | $71,000 | +9.2% | 1,658 | +7.1% | 0.00% | 0.0% |
| Q1 2021 | $65,000 | -4.4% | 1,548 | +6.5% | 0.00% | 0.0% |
| Q4 2020 | $68,000 | +6.2% | 1,453 | -3.3% | 0.00% | 0.0% |
| Q3 2020 | $64,000 | +166.7% | 1,503 | +205.5% | 0.00% | – |
| Q2 2020 | $24,000 | +20.0% | 492 | +11.1% | 0.00% | – |
| Q1 2020 | $20,000 | -9.1% | 443 | +22.7% | 0.00% | – |
| Q4 2019 | $22,000 | +4.8% | 361 | -3.2% | 0.00% | – |
| Q3 2019 | $21,000 | 0.0% | 373 | +0.5% | 0.00% | – |
| Q2 2019 | $21,000 | +40.0% | 371 | +25.3% | 0.00% | – |
| Q1 2019 | $15,000 | +36.4% | 296 | +7.6% | 0.00% | – |
| Q4 2018 | $11,000 | -26.7% | 275 | +31.0% | 0.00% | – |
| Q3 2018 | $15,000 | +650.0% | 210 | +577.4% | 0.00% | – |
| Q2 2018 | $2,000 | – | 31 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |